-
Global Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight
06 Aug 2025 17:00 GMT
… BioPharma, GSK, PharmaEssentia, Shire, Pfizer, Takeda, Teva Pharmaceuticals, Merck, and others
Myeloproliferative … BioPharma, GSK, PharmaEssentia, Shire, Pfizer, Takeda, Teva Pharmaceuticals, Merck, among others. Chronic …
-
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
31 Jul 2025 11:05 GMT
… HR roles at Abiomed and Shire. Kelley holds a bachelor’s … Medication Guide. About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical … ,390
$
885,051
APELLIS PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF …
-
Drug Safety Literature Searching Training Course | Explore Best Practices and Enhance Reporting Abilities (ONLINE EVENT: September 11-12, 2025) - ResearchAndMarkets.com
04 Aug 2025 18:14 GMT
… started his career at Ashbourne Pharmaceuticals in 1989 as Head of … Head of Global Pharmacovigilance at Shire Pharmaceuticals. He then set up his …
-
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13 Jun 2025 11:00 GMT
… Chief Executive Officer of Tonix Pharmaceuticals. “Having successfully built Tonix … acquisitions from companies such as Shire, Roche, Novartis and Sanofi. … Investor Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862 …
-
BioMarin Announces Appointment of Ian T. Clark to Board of Directors
01 Aug 2025 13:20 GMT
… AG, Sanofi S.A., Ivax Pharmaceuticals and G.D. Searle. Mr … Ltd., Kyverna Therapeutics, Inc., Corvus Pharmaceuticals, Inc. and Guardant Health, Inc … boards of Forty Seven Inc., Shire Pharmaceuticals, Inc., Avrobio, Inc. and Kite …
-
KU undergraduates Kyra Schrock and Ian Shire receive Courtwright Awards
11 Apr 2025 15:23 GMT
… poster event.
Ian Shire
Ian ShireIan Shire is a senior from … incredibly powerful tool," Shire said. “My work focuses … have utility in DNA-related pharmaceuticals/disease monitoring, … stability towards native nucleases.”
Shire has submitted an abstract …
-
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
15 Oct 2024 10:00 GMT
… Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer … by his co-founding of Shire Pharmaceuticals. He brings a wealth of …
-
Don’t dump our waste in the dunes say Tweed Shire residents
10 Feb 2025 22:24 GMT
… a clear message to Tweed Shire Council about better sewage treatment … for the campaign urging Tweed Shire Council to upgrade Hastings Point … region.
‘There were significantly fewer pharmaceuticals, illicit drugs, micro-plastics, pathogens …
-
Hereditary Angioedema Drug Market Expansion Forecasted at X% CAGR to X Billion USD by 2032 | Argenx, Shire ,CSL Behring
31 Jan 2025 08:08 GMT
… Include:
BioCryst Pharmaceuticals
Takeda Pharmaceutical Company Limited
Ionis Pharmaceuticals
argenx
Shire
CSL Behring …
Zealand Pharma A/S
Roche
Alnylam Pharmaceuticals …
-
QCS joining Apollo Care a ‘win-win’ for all
24 Jul 2025 09:29 GMT
Board members of not-for-profit aged care provider Quirindi Care Services today voted in favour of joining specialist regional aged care provider Apollo Care.
QCS referenced the increasingly challenging regulatory and operating environment – where 50 per …